UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000035696
Receipt No. R000040662
Official scientific title of the study Helicobacter pylori infection Influence the Adverse Cardiovascular Events
Date of disclosure of the study information 2019/01/28
Last modified on 2019/01/28 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Helicobacter pylori infection Influence the Adverse Cardiovascular Events
Title of the study (Brief title) HP infection Influence the Adverse Cardiovascular Events
Region
Japan

Condition
Condition Coronary heart disease
Classification by specialty
Cardiology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To examine the effect of Helicobacter pylori infection on adverse cardiovascular events.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Adverse Cardiovascular Events
Key secondary outcomes inflammatory markers

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients with coronary heart diseaase requring percutaneous coronary intervention
Key exclusion criteria 1) past history of eradication for Helicobacter pylori
2)end stage renal failure on hemodialysis
3)hemodynamically unstable condition
Target sample size 80

Research contact person
Name of lead principal investigator Daisuke Sueta
Organization Kumamoto University Hospital
Division name Department of Cardiovascular Medicine
Address 1-1-1 Honjo, Kumamoto City
TEL 096-373-5175
Email sueta-d@kumamoto-u.ac.jp

Public contact
Name of contact person Daisuke Sueta
Organization Kumamoto University Hospital
Division name Department of Cardiovascular Medicine
Address 1-1-1 Honjo, Kumamoto City
TEL 096-373-5175
Homepage URL
Email sueta-d@kumamoto-u.ac.jp

Sponsor
Institute Kumamoto University Hospital
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 28 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 01 Month 27 Day
Anticipated trial start date
2019 Year 01 Month 28 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information None

Management information
Registered date
2019 Year 01 Month 28 Day
Last modified on
2019 Year 01 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040662